Bixiye
P57-19 New Medical, Medical Drug and Behavioral Health Policy Management Updates for Commercial and Medicare Advantage Lines of Business
Taariikhda dhaqangalka Barnaamijka: Jul 01, 2019
Natiijooyinka Raadinta
Soo bandhiga 2251 - 2260 ee natiijooyinka 4296
Bixiye
QP64-19 Platinum Blue Choice Member Copays
Taariikhda wax ku ool ah ee barnaamijka: Jun 26, 2019
Bixiye
QP65-19 Denial, Termination, Reduction (DTR) Notices not Generated
Taariikhda wax ku ool ah ee barnaamijka: Jun 26, 2019
Bixiye
QP62-19 Pharmacy Benefit Update – New Drug-Related Prior Authorization with Quantity Limit Criteria: Interleukin 5 (IL-5) Inhibitors
Taariikhda wax ku ool ah ee barnaamijka: Jun 26, 2019
Bixiye
QP60-19 2019 Blue Cross Basic Seminars
Taariikhda wax ku ool ah ee barnaamijka: Jun 26, 2019
Bixiye
QP61-19 Availity Portal Authorization Frequently Asked Questions
Taariikhda wax ku ool ah ee barnaamijka: Jun 26, 2019
Bixiye
QP63-19 When the Authorization Tool is Utilized on the Availity Portal
Taariikhda wax ku ool ah ee barnaamijka: Jun 26, 2019
Bixiye
QP58-19 Pharmacy Benefit Exclusion for Zolgensma (onasemnogene abeparvovec-xioi) Injection
Taariikhda wax ku ool ah ee barnaamijka: Jun 12, 2019
Bixiye
QP56-19 Pharmacy Benefit Update – New Drug-Related Step Therapy Criteria: Topical Corticosteroids
Taariikhda wax ku ool ah ee barnaamijka: Jun 12, 2019
Bixiye
QP48-19 Pharmacy Benefit Update – New Drug-Related Prior Authorization with Quantity Limit Criteria: Somatostatin Analogs
Taariikhda wax ku ool ah ee barnaamijka: Jun 12, 2019